Table 3

Incidence rate (95% CI)/1000 person-years according to statin use and age

Any statin useNo statin use
VTEDVTPEVTEDVTPE
Age (years)
≤507.4 (5.9 to 9.1)4.6 (3.5 to 6.1)3.5 (2.6 to 4.8)46.8 (45.8 to 47.8)28.6 (27.9 to 29.4)19.3 (18.7 to 20.0)
51–6029.8 (25.4 to 34.9)17.5 (14.3 to 21.3)11.8 (9.3 to 14.9)44.8 (43.8 to 45.8)27.5 (26.7 to 28.3)18.6 (18.0 to 19.2)
61–7030.4 (26.7 to 34.5)16.4 (13.9 to 19.4)13.9 (11.6 to 16.7)45.0 (44.0 to 46.0)27.7 (27.0 to 28.5)18.6 (18.0 to 19.2)
71–8036.6 (32.1 to 41.8)16.2 (13.3 to 19.6)21.3 (18.0 to 25.2)44.6 (43.6 to 45.6)27.6 (26.8 to 28.4)18.3 (17.7 to 18.9)
>8052.2 (42.1 to 64.8)19.7 (14.0 to 27.7)33.1 (25.4 to 43.1)44.3 (43.3 to 45.2)27.3 (26.5 to 28.0)18.2 (17.7 to 18.8)
All24.4 (22.8 to 26.2)12.7 (11.5 to 13.9)12.3 (11.1 to 13.5)48.5 (47.4 to 49.7)30.3 (29.4 to 31.1)19.6 (19.0 to 20.3)
  • DVT, deep venous thrombosis; PE, pulmonary embolism; VTE, venous thromboembolism.